There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

Alzheimer's Association advocates push for public health outreach on Alzheimer's and dementia in Indiana. Insurance coverage and education campaigns are key.

Alzheimer's disease is at the center of a revolutionary theory in neuroscience, where the mysteries of the human brain ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...

Frontotemporal dementia (FTD) can be hard to diagnose, because it is an uncommon type of dementia and does not cause memory problems at first. However, there are some ways to diagnose FTD including ...

Getting an accurate and timely diagnosis of dementia is important. However, for younger people it can often take much longer. There can be specific reasons for this, including: Young-onset dementia is ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

On a Tuesday edition of FOX45 Morning News, Shannon Lilly spoke with Catherine Addy, a Coppin State University student and intern with the Alzheimer's Association of Greater Maryland, about a new ...

Valentine's Day is a day of presenting your love for that special someone in your life, but not everyone is able to fully ...